通过可逆衰变来直接交换制药中的碳同位素
Minghao Feng1, Joao De Oliveira1,2, Antoine Sallustrau1
1Université Paris Saclay, CEA, DMTS, Service de Chimie Bio-organique et Marquage, 91191 Gif-sur-Yvette, France.
Journal of the American Chemical Society
|April 7, 2021
概括
研究人员开发了一种使用碳-14.4的新方法,用于在芳酸上进行碳同位素交换. 这种技术简化了放射性标记,减少了药物开发和ADME研究的成本和浪费.
科学领域:
- 有机化学 有机化学
- 放射化学 放射化学是指辐射化学.
- 药用化学 医学化学
背景情况:
- 碳-14 (C) 标签对于追踪有机分子在制药开发,作物科学和食品安全方面至关重要.
- 目前加入14C的方法可能很复杂,需要进行结构修改,并产生大量的放射性废物.
研究的目的:
- 开发一种高效的过渡金属催化过程,用于在芳酸上进行碳同位素交换.
- 为了使含有亚酸盐的化合物在不改变其结构的情况下直接标记14C.
主要方法:
- 用过渡金属催化反应来进行碳同位素交换.
- 使用了放射性标记的前体化 (Zn([14C]CN) 2) 的研究.
- 该协议允许单个步骤将14C纳入芳酸.
主要成果:
- 成功建立了一种引入14C到芳酸的新方法.
- 该方法使直接标签更容易,而不需要预先存在的结构修改.
- 该过程是高效的,并减少合成成本和放射性废物产生.
结论:
- 这项新协议大大简化了含有亚的分子的放射性标记.
- 预计它将在药物开发中加速基于C的吸收,分布,新陈代谢和分泌 (ADME) 研究.
- 该方法为各种科学应用提供了具有成本效益和环保意识的放射性标记方法.
相关概念视频
Hepatic Drug Excretion: Enterohepatic Cycling
2.1K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.1K
Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems
247
Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative...
247
Phase I Reactions: Reductive Reactions
370
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
370
Phase II Conjugation Reactions: Overview
513
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
513
Drug Biotransformation: Overview
3.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.2K
Drug Biotransformation: Overview
2.0K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.0K


